Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of Infants at Risk for Developing Fabry, Pompe, or Mucopolysaccharidosis-I from Newborn Blood Spots by Tandem Mass Spectrometry

1 Mar 2013

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Research and Pathophysiology
Share to Lysosomal Storage Disorders Research
Share to Metabolism and Genetic Disorders

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 23465405
DOI: 10.1016/j.jpeds.2013.01.031

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of Infants at Risk for Developing Fabry, Pompe, or Mucopolysaccharidosis-I from Newborn Blood Spots by Tandem Mass SpectrometryPMID 23465405Read ↗

Universal screening for inherited metabolic diseases in the neonate (and the fetus)Semantic proximity Read ↗

A Non-targeted Proteomics Newborn Screening Platform for Genetic DisordersSemantic proximity Read ↗

Umbilical Cord Blood Sampling for Newborn Screening of Pompe Disease and the Detection of a Novel Pathogenic Variant and Pseudodeficiency Variants in an Asian populationSemantic proximity Read ↗

Newborn Screening for Fabry Disease: Current Status of KnowledgeSemantic proximity Read ↗

Analytical Validation of a Genomic Newborn Screening WorkflowSemantic proximity Read ↗

Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria.Semantic proximity Read ↗

The Multi-Omic Approach to Newborn Screening: Opportunities and ChallengesSemantic proximity Read ↗

Newborn Screening for Pompe Disease: Pennsylvania ExperienceSemantic proximity Read ↗

Whole Genome Sequencing from Dried Blood Spots for Newborn Screening of Menkes Disease and 36 Other Actionable Inherited Neurometabolic DisordersSemantic proximity Read ↗

Whole genome sequencing from dried blood spots for newborn screening of Menkes disease and 36 other actionable inherited neurometabolic disorders.Semantic proximity Read ↗

Infantile-onset Pompe disease with neonatal debut: A case report and literature review.Semantic proximity Read ↗

Newborn Screening for Methylmalonic Acidemia/propionic Acidemia: Systematic Evaluation of a Two-pronged Approach Based on MS/MS and UPLC-MS/MSSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.